Showing results (11-20 of 24) with videos related to
Sort By:
Pageof 3
Journal of Neural Transmission. Supplementum|January 1, 1990
Monoamine oxidase and semicarbazide-sensitive amine oxidase activities in bovine eyeA Fernandez de Arriba, D Balsa, K F Tipton, et al.Biochemical Pharmacology|November 27, 1991
Contribution of different amine oxidases to the metabolism of dopamine in bovine retinaA Fernández de Arriba, J M Lizcano, D Balsa, et al.The Journal of Pharmacy and Pharmacology|October 1, 1994
Inhibition of monoamine oxidase from bovine retina by beta-carbolinesA Fernández de Arriba, J M Lizcano, M D Balsa, et al.British Journal of Pharmacology|July 1, 1996
Effects of UR-12633, a new antagonist of platelet-activating factor, in rodent models of endotoxic shockM Giral, D Balsa, R Ferrando, et al.Journal of Medicinal Chemistry|January 19, 1996
Design, synthesis, and structure-activity relationship studies of novel 1-[(1-acyl-4-piperidyl)methyl]-1H-2- methylimidazo[4,5-c]pyridine derivatives as potent, orally active platelet-activating factor antagonistsE Carceller, M Merlos, M Giral, et al.Biochemical Pharmacology|June 9, 1993
The effect of side chain substitution at positions 2 and 3 of the heterocyclic ring of N-acetylenic analogues of tryptamine as monoamine oxidase inhibitorsM Avila, M D Balsa, E Fernandez-Alvarez, et al.Journal of Pharmacological and Toxicological Methods|September 1, 1996
Characterization of [3H]apafant binding to PAF receptor on rabbit platelet membranes: a comparison of a microplate filtration system and a standard methodD Balsa, M Merlos, M Giral, et al.Drugs Under Experimental and Clinical Research|January 1, 1997
Effects of a new platelet-activating factor antagonist, UR-12670, on several endotoxic shock markers in ratsD Balsa, M Merlos, M Giral, et al.Journal of Lipid Mediators and Cell Signalling|September 26, 1997
Effect of endotoxin and platelet-activating factor on rat vascular permeability: role of vasoactive mediatorsD Balsa, M Merlos, M Giral, et al.The Journal of Pharmacology and Experimental Therapeutics|January 1, 1997
Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF)M Merlos, M Giral, D Balsa, et al.Pageof 3